Saroja Pharma Ind Peer Comparison
NSE: SAROJA
₹38.95
As on 02-Sep-2026IST
Market cap
₹16 Cr
Revenue (TTM)
₹54 Cr
P/E Ratio
10.2
P/B Ratio
1.1
Div. Yield
0 %
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
16 | 650 | 413 | 227 | 180 |
Revenue (₹ Cr) |
54 | 26 | 601 | 453 | 89 |
Net Profit (₹ Cr) |
1.03 | 20.26 | 18.67 | 8.45 | 55.73 |
Net Margin (%) |
1.92 | 39.51 | 3.04 | 1.86 | 67.25 |
RoE (%) |
6.82 | 0.77 | 14.85 | 16.68 | 12.22 |
Price to Earnings |
10.18 | 32.10 | 22.14 | 26.55 | 3.23 |
Price-To-Book |
1.05 | 0.28 | 3.02 | 3.97 | 0.37 |
Income Statement (₹ Cr)
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Operating Revenue
|
53.73 | 111.51 | 625.25 | 331.49 | 40.34 |
|
Total Income
|
53.91 | 117.63 | 630.26 | 332.32 | 40.41 |
|
Total Expenditure
|
50.94 | 115.33 | 599.71 | 321.78 | 18.35 |
|
EBITDA
|
2.79 | -3.82 | 25.54 | 9.71 | 21.99 |
|
Depreciation
|
0.11 | 0.75 | 0.10 | 3.59 | 0.59 |
|
EBIT
|
2.67 | -4.57 | 25.44 | 6.12 | 21.40 |
|
Interest
|
1.41 | 1.32 | 0.04 | 1.66 | 4.87 |
|
Other Income
|
0.19 | 6.12 | 5.01 | 0.82 | 0.07 |
|
Exceptional Items
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
1.45 | 0.23 | 30.40 | 4.99 | 16.60 |
|
Provision for Tax
|
0.42 | -0.05 | 8.07 | 1.34 | -2.28 |
|
Profit after Tax
|
1.03 | 0.28 | 22.33 | 3.65 | 18.88 |
Liabilities (₹ Cr)
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
15.68 | 2,741.65 | 126.67 | 49.68 | 449.69 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
1.39 | 98.22 | 0.56 | 1.00 | 12.36 |
|
Current Liabilities
|
22.49 | 1.84 | 140.74 | 22.75 | 61.02 |
|
Total Liabilities
|
39.55 | 2,841.71 | 268.15 | 73.66 | 523.07 |
Assets (₹ Cr)
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
12.34 | 2,825.45 | 1.53 | 16.70 | 377.84 |
|
Current Assets
|
27.22 | 16.26 | 266.43 | 56.73 | 145.22 |
|
Total Assets
|
39.55 | 2,841.71 | 268.15 | 73.66 | 523.07 |
|
Total Debt*
|
9.46 | 0.00 | 0.49 | 21.50 | 57.37 |
|
Net Current Assets
|
4.73 | 14.42 | 125.69 | 33.98 | 84.20 |
|
Contingent Liabilities
|
-- | 23.78 | 6.45 | -- | -- |
Cashflow (₹ Cr)
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1.15 | -2.72 | 23.71 | -10.53 | -15.25 |
|
Cash Flow from Investing Activities
|
-2.70 | 52.77 | -6.07 | 0.97 | 20.68 |
|
Cash from Financing Activities
|
1.56 | -40.96 | -12.38 | 7.38 | -6.12 |
|
Net Cash Inflow / Outflow
|
0.01 | 9.09 | 5.26 | -2.17 | -0.69 |
Ratios
Profitability Ratios
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
ROCE (%)
|
12.56 | 0.07 | 24.91 | 10.26 | 4.31 |
|
ROE (%)
|
6.82 | 0.01 | 18.35 | 7.49 | 4.31 |
|
ROA (%)
|
3.13 | 0.01 | 7.79 | 5.42 | 3.66 |
|
EBIT Margin (%)
|
5.53 | 2.06 | 4.88 | 3.18 | 54.67 |
|
Net Margin (%)
|
1.92 | 0.24 | 3.54 | 1.10 | 46.73 |
|
Cash Profit Margin (%)
|
2.14 | 0.93 | 3.59 | 2.18 | 48.27 |
Growth Ratios
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
32.11 | 120.17 | 4.73 | 57.39 | 23.83 |
|
EBIT Growth (%)
|
8.05 | -94.22 | 2.43 | 63.58 | -87.80 |
|
Net Profit Growth (%)
|
17.75 | -99.28 | 2.24 | 233.00 | -87.25 |
|
EPS Growth (%)
|
17.75 | -99.28 | 2.24 | 233.00 | -87.25 |
|
Book Value Growth (%)
|
7.06 | 34.51 | 8.47 | 4.00 | 5.48 |
Valuation Ratios
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Price / Earnings
|
14.68 | 3,897.50 | 23.22 | 147.44 | 8.52 |
|
Price / Book Value
|
0.97 | 0.42 | 4.09 | 10.84 | 0.36 |
|
Dividend Yield (%)
|
0.00 | 0.32 | 2.48 | 0.32 | 0.59 |
|
EV/EBITDA
|
8.17 | 464.68 | 16.62 | 52.95 | 9.84 |
|
Market Cap (₹ Cr)
|
15.18 | 1,084.22 | 518.58 | 538.31 | 160.86 |
Solvency Ratios
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.60 | 0.00 | 0.00 | 0.43 | 0.13 |
|
Short term debt to equity ratio
|
0.52 | -- | -- | 0.38 | 0.13 |
|
Current Ratio
|
1.21 | 8.83 | 1.89 | 2.49 | 2.38 |
|
Quick Ratio
|
1.21 | 8.83 | 1.44 | 2.38 | 2.38 |
|
Interest Coverage
|
2.03 | 1.17 | 761.03 | 4.00 | 4.41 |
Operating Efficiency Ratios
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
49.47 | -- | 16.76 | 15.28 | 10.48 |
|
Asset Turnover
|
1.63 | 0.05 | 2.18 | 4.92 | 0.08 |
|
Receivable days
|
145.45 | 0.00 | 61.60 | 44.79 | 38.78 |
|
Inventory Days
|
1.69 | 0.00 | 53.44 | 2.41 | 0.00 |
|
Payable days
|
74.63 | 3.66 | 95.05 | 1.62 | 110.47 |
|
Cash Conversion Cycle
|
72.51 | -3.66 | 19.99 | 45.58 | -71.70 |